Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants.
about
Splice Variants of Androgen Receptor and Prostate CancerParacrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironmentStilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cellsThe link between androgen receptor splice variants and castration-resistant prostate cancer.Constitutive activity of the androgen receptor.Overexpression of 17β-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death.High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting.Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor GrowthMechanisms of drug resistance that target the androgen axis in castration resistant prostate cancer (CRPC).Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells.Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.Classical and Non-Classical Roles for Pre-Receptor Control of DHT Metabolism in Prostate Cancer Progression.High levels of the AR-V7 Splice Variant and Co-Amplification of the Golgi Protein Coding YIPF6 in AR Amplified Prostate Cancer Bone Metastases.The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone.Transcript level of AKR1C3 is down-regulated in gastric cancer.Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons.In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3).Androgen synthesis in prostate cancer: do all roads lead to Rome?DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.Clinical relevance of androgen receptor alterations in prostate cancer.Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer.A carbon 21 steroidal metabolite from progestin, 20β-hydroxy-5α-dihydroprogesterone, stimulates the androgen receptor in prostate cancer cells.Modulation of AKR1C2 by Curcumin Decreases Testosterone Production in Prostate Cancer.Exploring vitamin D metabolism and function in cancer.Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities.Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
P2860
Q26740592-D9F25110-3C16-46F3-9519-B789CDFDE950Q28278828-5604ADB1-5A52-4038-897C-CE3B8A0D570CQ28539233-066544C9-FBC3-45AF-BF8B-F36F5ADA1B89Q30618562-9F1B10B9-D681-44CA-ADC7-56D59F180327Q34775572-606737E5-3801-4112-B899-B21444E42F3CQ35257779-2B14001C-1E32-4976-91B6-AD5BCC82C810Q35821224-58E5AB7A-59A6-4335-863E-BFD2C7E38C39Q36046653-A38F2F2D-D35E-403A-AA19-2493B874C2A4Q36055229-DE8ED012-00BD-4399-883A-E8C68362F4D6Q37306965-F0C2B42F-624B-4369-A683-EAFB0E6FEC42Q38336321-C0C1E7FA-9124-4B63-8230-7DDE2C98882BQ38707335-0D7BC19E-A722-4D98-BF3F-A724579E5F17Q38718521-3D7C63CD-C89A-41E2-9915-806E769890E1Q38756694-FB0229D7-139E-4DE4-BEFE-7A9271215F2DQ38782882-616D6570-5771-460D-8351-F2462DC4A7BBQ38796540-DA5C6E71-E8C1-4A2A-9971-A973970D6294Q38979373-C3CD3A82-F86C-4E80-8E03-806A9518DE28Q39002780-C37BABEE-2484-4CFF-AA46-CC29177345E8Q40581966-8771350C-D458-49AC-889C-923720CEF4C8Q42377108-A40B538F-D414-4195-ADFB-00BDD62E5F0EQ42530532-9F530A54-7B1D-494B-8279-935C56C05454Q48197264-B3CFD1CD-3E7D-4670-8AFC-84FD7DDE36E1Q49711327-71318444-19F2-4D89-815B-AEF1C9838F76Q52587327-C0F18EA1-C7D1-4969-B9E2-04306DE773CBQ52683959-BA3A7086-18E1-4CC9-B7FD-076391510BACQ55003255-5A819609-CC01-4E62-AE9C-B2297399FCFB
P2860
Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Characterization of prostate c ...... ogen receptor splice variants.
@en
Characterization of prostate c ...... ogen receptor splice variants.
@nl
type
label
Characterization of prostate c ...... ogen receptor splice variants.
@en
Characterization of prostate c ...... ogen receptor splice variants.
@nl
prefLabel
Characterization of prostate c ...... ogen receptor splice variants.
@en
Characterization of prostate c ...... ogen receptor splice variants.
@nl
P2093
P2860
P1433
P1476
Characterization of prostate c ...... ogen receptor splice variants.
@en
P2093
Anders Bergh
Anders Widmark
Elin Thysell
Emma Jernberg
Erik Bovinder Ylitalo
Pernilla Wikström
Sead Crnalic
Stina Rudolfsson
P2860
P304
P356
10.1371/JOURNAL.PONE.0077407
P407
P577
2013-11-07T00:00:00Z